Effect of polyphenols on oxidative stress and mitochondrial dysfunction in neuronal death and brain edema in cerebral ischemia

International Journal of Molecular Sciences

Volumn 12, Issue 11, 2011, Pages 8181-8207

  Panickar, Kiran S ^a   Anderson, Richard A ^a  

^a BELTSVILLE HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Apoptosis; Edema; Glia; Inflammation; Ischemia; mPT

Indexed keywords

2,3,5,4 TETRAHYDROXYSTILBENE 2 O BETA DEXTRO GLUCOSIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5,7,3',4',5' PENTAHYDROXYDIHYDROFLAVANOL 3 O (2'' O GALLOYL)BETA DEXTRO GLUCOPYRANOSIDE; ALPHA TOCOPHEROL; ANTIOXIDANT; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3; CASPASE 9; CASPASE ACTIVATED DEOXYRIBONUCLEASE; CATECHIN; CURCUMIN; CYCLOSPORIN A; CYTOCHROME C; CYTOCHROME C OXIDASE; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; INTERCELLULAR ADHESION MOLECULE 1; MANGIFERIN; MORIN; MYELOPEROXIDASE; MYRICETIN; N,N DIMETHYLSPHINGOSINE; POLYPHENOL DERIVATIVE; PROTEIN BAD; PROTEIN BAX; QUERCETIN; RESVERATROL; TACROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG; PLANT EXTRACT; POLYPHENOL;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BRAIN EDEMA; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; CELL SWELLING; CELL VIABILITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA FRAGMENTATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME ACTIVATION; HUMAN; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; REVIEW; SINGLE DRUG DOSE; TRANSIENT ISCHEMIC ATTACK; ANIMAL; APOPTOSIS; CELL DEATH; DISEASE MODEL; DRUG EFFECTS; GLIA; MITOCHONDRION; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BRAIN EDEMA; BRAIN ISCHEMIA; CELL DEATH; DISEASE MODELS, ANIMAL; HUMANS; MITOCHONDRIA; NEUROGLIA; OXIDATIVE STRESS; PLANT EXTRACTS; POLYPHENOLS;

EID: 82255172218     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms12118181     Document Type: Review

References (215)

1. Bravo, L. Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 1998, 56, 317-333.
2. Manach, C.; Scalbert, A.; Morand, C.; Remesy, C.; Jimenez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727-747.
3. Ross, J.A.; Kasum, C.M. Dietary flavonoids: Bioavailability, metabolic effects, and safety. Ann. Rev. Nutr. 2002, 22, 19-34.
4. Hendrich, A.B. Flavonoid-membrane interactions: Possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol. Sin. 2006, 27, 27-40.
5. Han, X.; Shen, T.; Lou, H. Dietary polyphenols and their biological significance. Int. J. Mol. Sci. 2007, 8, 950-988.
6. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell. Longev. 2009, 2, 270-278.
7. Neuhouser, M.L. Dietary flavonoids and cancer risk: Evidence from human population studies. Nutr. Cancer 2004, 50, 1-7.
8. Arts, I.C.; Hollman, P.C. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S-325S.
9. Howes, M.J.; Perry, E. The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 2011, 28, 439-468.
10. Broekhuizen L.N.; van Wijk, D.F.; Vink, H.; Stalmach, A.; Crozier, A.; Hutten, B.A.; Kastelein, J.J.; Hugenholtz, P.G; Koenig, W.; Stroes, E.S. Reduction of monocyte chemoattractant protein 1 and macrophage migration inhibitory factor by a polyphenol-rich extract in subjects with clustered cardiometabolic risk factors. Br. J. Nutr. 2011, 28, 1-7.
11. Hammerstone J.F.; Lazarus, S.A.; Schmitz, H.H. Procyanidin content and variation in some commonly consumed foods. J. Nutr. 2000, 130, 2086S-2092S.
12. Seeram, N.P. Bioactive Polyphenols from Foods and Dietary Supplements: Challenges and Opportunities. In Herbs: Challenges in Chemistry and Biology, ACS Symposium Series 925 (Herbs); Ho, C.T., Wang, M., Sang, S., Eds.; Oxford University Press: New York, NY, USA 2006; Chapter 3, pp. 25-38.
13. Martin, K.R.; Appel, C.L. Polyphenols as dietary supplements: A double-edged sword. Nutr. Dietary Suppl. 2010, 2, 1-12.
14. Justesen, U.; Knuthsen, P.; Leth, T. Determination of plant polyphenols in Danish foodstuffs by HPLC-UV and LC-MS detection. Cancer Lett. 1997, 114, 165-167.
15. Chun, O.K.; Chung, S.J.; Song, W.O. Estimated dietary flavonoid intake and major food sources of U.S. adults. J. Nutr. 2007, 137, 1244-1252.
16. Ovaskainen, M.L.; Törrönen, R.; Koponen, J.M.; Sinkko, H.; Hellström, J.; Reinivuo, H.; Mattila, P. Dietary intake and major food sources of polyphenols in Finnish adults. J. Nutr. 2008, 138, 562-566.
17. Williamson, G.; Holst, B. Dietary reference intake (DRI) value for dietary polyphenols: are we heading in the right direction? Br. J. Nutr. 2008, 99, S55-S58.
18. Arab, L.; Liu, W.; Elashoff, D. Green and black tea consumption and risk of stroke: A meta-analysis. Stroke 2009, 40, 1786-1792.
19. Hollman, P.C.; Geelen, A.; Kromhout, D. Dietary flavonol intake may lower stroke risk in men and women. J. Nutr. 2010, 140, 600-604.
20. Wexler, B.C. Metabolic changes in response to acute cerebral ischemia following bilateral carotid artery ligation in arteriosclerotic versus nonarteriosclerotic rats. Stroke 1970, 1, 112-121.
21. Martins, E.; Inamura, K.; Themner, K.; Malmqvist, K.G.; Siesjö, B.K. Accumulation of calcium and loss of potassium in the hippocampus following transient cerebral ischemia: A proton microprobe study. J. Cereb. Blood Flow Metab. 1988, 8, 531-538.
22. Choi, D.W. Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage. Trends Neurosci. 1988, 11, 465-469.
23. Panickar, K.S.; Norenberg, M.D. Astrocytes in cerebral ischemic injury: Morphological and general considerations. Glia 2005, 50, 287-298.
24. Cooper, A.J.; Pulsinelli, W.A.; Duffy, T.E. Glutathione and ascorbate during ischemia and postischemic reperfusion in rat brain. J. Neurochem. 1980, 35, 1242-1245.
25. Kogure, K.; Watson, B.D.; Busto, R.; Abe, K. Potentiation of lipid peroxides by ischemia in rat brain. Neurochem Res. 1982, 4, 437-454.
26. Sims, N.R.; Muyderman, H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim. Biophys. Acta 2010, 1802, 80-91.
27. Snider, B.J.; Gottron, F.J.; Choi, D.W. Apoptosis and necrosis in cerebrovascular disease. Ann. NY Acad. Sci. 1999, 893, 243-253.
28. Nicotera, P.; Melino, G. Regulation of the apoptosis-necrosis switch. Oncogene 2004, 23, 2757-2765.
29. Broughton, B.R.; Reutens, D.C.; Sobey, C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40, e331-e339.
30. Shaham, S.; Horvitz, H.R. Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev. 1996, 10, 578-591.
31. Green, D.; Kroemer, G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 1998, 8, 267-271.
32. Berlin, V.; Haseltine, W.A. Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J. Biol. Chem. 1981, 256, 4747-4756.
33. Ramakrishnan, N.; McClain, D.E.; Catravas, G.N. Membranes as sensitive targets in thymocyte apoptosis. Int. J. Radiat. Biol. 1993, 63, 693-701.
34. Susin, S.A.; Lorenzo, H.K.; Zamzami, N.; Marzo, I.; Snow, B.E.; Brothers, G.M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397, 441-446.
35. Wang, X.; Yang, C.; Chai, J.; Shi, Y.; Xue, D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 2002, 298, 1587-1592.
36. Penninger, J.M.; Kroemer, G. Mitochondria, AIF and caspases--rivaling for cell death execution. Nat. Cell Biol. 2003, 5, 97-99.
37. Hayashi, T.; Sakurai, M.; Itoyama, Y.; Abe, K. Oxidative damage and breakage of DNA in rat brain after transient MCA occlusion. Brain Res. 1999, 832, 159-163.
38. Boveris, A. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv. Exp. Med. Biol. 1977, 78, 67-82.
39. Gasche, Y.; Copin, J.-C.; Sugawara, T.; Fujimura, M.; Chan, P.H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 2001, 21, 1393-1400.
40. Liu, K.J.; Rosenberg, G.A. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol. Med. 2005, 39, 71-80.
41. Van Lint, P.; Libert, C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J. Leukoc. Biol. 2007, 82, 1375-1381.
42. Asahi, M.; Wang, X.; Mori, T.; Sumii, T.; Jung, J.-C.; Moskowitz, M.A.; Fini, M.E.; Lo, E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001, 21, 7724-7732.
43. Li, Y.; Chopp, M.; Jiang, N.; Zaloga, C. In situ detection of DNA fragmentation after focal cerebral ischemia in mice. Brain Res. Mol. Brain Res. 1995, 28, 164-168.
44. Li, Y.; Chopp, M.; Jiang, N.; Zhang, Z.G.; Zaloga, C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke 1995, 26, 1252-1258.
45. Pantoni, L.; Garcia, J.H.; Gutierrez, J.A. Cerebral white matter is highly vulnerable to ischemia. Stroke 1996, 27, 1641-1646; discussion 1647.
46. Honkaniemi, J.; Massa, S.M.; Breckinridge, M.; Sharp, F.R. Global ischemia induces apoptosis-associated genes in hippocampus. Brain Res. Mol. Brain Res. 1996, 42, 79-88.
47. Krajewski, S.; Krajewska, M.; Ellerby, L.M.; Welsh, K.; Xie, Z.; Deveraux, Q.L.; Salvesen, G.S.; Bredesen, D.E.; Rosenthal, R.E.; Fiskum, G.; Reed, J.C. Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc. Natl. Acad. Sci. USA 1999, 96, 5752-5757.
48. Chen, J.; Nagayama, T.; Jin, K.; Stetler, R.A.; Zhu, R.L.; Graham, S.H.; Simon, R.P. Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia. J. Neurosci. 1998, 18, 4914-4928.
49. Schmidt-Kastner, R.; Fliss, H.; Hakim, A.M. Subtle neuronal death in striatum after short forebrain ischemia in rats detected by in situ end-labeling for DNA damage. Stroke 1997, 28, 163-169; discussion 169-170.
50. Candelario-Jalil, E.; Mhadu, N.H.; Al-Dalain, S.M.; Martínez, G.; León, O.S. Time course of oxidative damage in different brain regions following transient cerebral ischemia in gerbils. Neurosci. Res. 2001, 41, 233-241.
51. Endres, M.; Namura, S.; Shimizu-Sasamata, M.; Waeber, C.; Zhang, L.; Gómez-Isla, T.; Hyman, B.T.; Moskowitz, M.A. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 1998, 18, 238-247.
52. Wiessner, C.; Sauer, D.; Alaimo, D.; Allegrini, P.R. Protective effect of a caspase inhibitor in models for cerebral ischemia in vitro and in vivo. Cell. Mol. Biol. (Noisy-le-grand) 2000, 46, 53-62.
53. Inoue, S.; Drummond, J.C.; Davis, D.P.; Cole, D.J.; Patel, P.M. Combination of isoflurane and caspase inhibition reduces cerebral injury in rats subjected to focal cerebral ischemia. Anesthesiology 2004, 101, 75-81.
54. Hall, E.D.; Pazara, K.E.; Braughler, J.M. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils. Stroke 1988, 19, 997-1002.
55. Hara, H.; Kato, H.; Kogure, K. Protective effect of alpha-tocopherol on ischemic neuronal damage in the gerbil hippocampus. Brain Res. 1990, 510, 335-338.
56. Kim, D.W.; Eum, W.S.; Jang, S.H.; Kim, S.Y.; Choi, H.S.; Choi, S.H.; An, J.J.; Lee, S.H.; Lee, K.S.; Han, K., et al. Transduced Tat-SOD fusion protein protects against ischemic brain injury. Mol. Cells 2005, 19, 88-96.
57. Clemens, J.A.; Ho, P.P.; Panetta, J.A. LY178002 reduces rat brain damage after transient global forebrain ischemia. Stroke 1991, 22, 1048-1052.
58. Andrus, P.K., Fleck, T.J., Oostveen, J.A., Hall, E.D. Neuroprotective effects of the novel brainpenetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons. J. Neurosci. Res. 1997, 47, 650-654.
59. Yu, Z.F.; Bruce-Keller, A.J.; Goodman, Y.; Mattson, M.P. Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J. Neurosci. Res. 1998, 53, 613-625.
60. Chan, P.H.; Kawase, M.; Murakami, K.; Chen, S.F.; Li, Y.; Calagui, B.; Reola, L.; Carlson, E.; Epstein, C.J. Over expression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 1998, 18, 8292-8299.
61. Davey, G.P.; Canevari, L.; Clark, J.B. Threshold effects in synaptosomal and nonsynaptic mitochondria from hippocampal CA1 and paramedian neocortex brain regions. J. Neurochem. 1997, 69, 2564-2570.
62. Sims, N.R. Selective impairment of respiration in mitochondria isolated from brain subregions following transient forebrain ischemia in the rat. J. Neurochem. 1991, 56, 1836-1844.
63. Kostron, H.; Sperl, W.; Murr, C.; Pillwein, K. Effect of the calcium entry blocker nimodipine on the metabolism of nucleic acids in rat brain ischemia. Adv. Neurol. 1990, 52, 133-139.
64. Rosenthalm, M.; Feng, Z.C.; Raffin, C.N.; Harrison, M.; Sick, T.J. Mitochondrial hyperoxidation signals residual intracellular dysfunction after global ischemia in rat neocortex. J. Cereb. Blood Flow Metab. 1995, 15, 655-665.
65. Taniuchi, H.; Fujibayashi, Y.; Yonekura, Y.; Konishi, J.; Yokoyama, A. Hyperfixation of copper-62-PTSM in rat brain after transient global ischemia. J. Nucl. Med. 1997, 38, 1130-1134.
66. Zaidan, E.; Sheu, K.F.; Sims, N.R. The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats. J. Neurochem. 1998, 70, 233-241.
67. Pérez-Pinzón, M.A.; Xu, G.P.; Born, J.; Lorenzo, J.; Busto, R.; Rosenthal, M.; Sick, T.J. Cytochrome C is released from mitochondria into the cytosol after cerebral anoxia or ischemia. J. Cereb. Blood Flow Metab. 1999, 19, 39-43.
68. Sugawara, T.; Fujimura, M.; Morita-Fujimura, Y.; Kawase, M.; Chan, P.H. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 1999, 19, RC39.
69. Liu, R.R.; Murphy, T.H. Reversible cyclosporin A-sensitive mitochondrial depolarization occurs within minutes of stroke onset in mouse somatosensory cortex in vivo: A two-photon imaging study. J. Biol. Chem. 2009, 284, 36109-36117.
70. Kuroda, S.; Katsura, K.; Hillered, L.; Bates, T.E.; Siesjö, B.K. Delayed treatment with alphaphenyl- N-tert-butyl nitrone (PBN) attenuates secondary mitochondrial dysfunction after transient focal cerebral ischemia in the rat. Neurobiol. Dis. 1996, 3, 149-157.
71. Canevari, L.; Kuroda, S.; Bates, T.E.; Clark, J.B.; Siesjö, B.K. Activity of mitochondrial respiratory chain enzymes after transient focal ischemia in the rat. J. Cereb. Blood Flow Metab. 1997, 17, 1166-1169.
72. Xu, L.; Voloboueva, L.A.; Ouyang, Y.; Emery, J.F.; Giffard, R.G. Over expression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J. Cereb. Blood Flow Metab. 2009, 29, 365-374.
73. Fujimura, M.; Morita-Fujimura, Y.; Murakami, K.; Kawase, M.; Chan, P.H. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 1998, 18, 1239-1247.
74. Matsumoto, S.; Friberg, H.; Ferrand-Drake, M.; Wieloch, T. Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1999, 19, 736-741.
75. Chen, H.; Hu, C.J.; He, Y.Y.; Yang, D.I.; Xu, J.; Hsu, C.Y. Reduction and restoration of mitochondrial dna content after focal cerebral ischemia/reperfusion. Stroke 2001, 32, 2382-2387.
76. Anderson, M.F.; Sims, N.R. The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions. J. Neurochem. 2002, 81, 541-549.
77. Takeda, Y.; Pérez-Pinzón, M.A.; Ginsberg, M.D.; Sick, T.J. Mitochondria consume energy and compromise cellular membrane potential by reversing ATP synthetase activity during focal ischemia in rats. J. Cereb. Blood Flow Metab. 2004, 24, 986-992.
78. Livnat, A.; Barbiro-Michaely, E.; Mayevsky, A. Real-time monitoring of spatial and temporal metabolic changes during focal cerebral ischemia in rats. Brain Res. 2011, 1389, 125-132.
79. Hoshi, A.; Yamamoto, T.; Shimizu, K.; Sugiura, Y.; Ugawa, Y. Chemical preconditioning-induced reactive astrocytosis contributes to the reduction of post-ischemic edema through aquaporin-4 down regulation. Exp. Neurol. 2011, 227, 89-95.
80. Urquiaga, I.; Leighton, F. Plant polyphenol antioxidants and oxidative stress. Biol. Res. 2000, 33, 55-64.
81. Dajas, F.; Rivera-Megret, F.; Blasina, F.; Arredondo, F.; Abin-Carriquiry, J.A.; Costa, G.; Echeverry, C.; Lafon, L.; Heizen, H.; Ferreira, M., et al. Neuroprotection by flavonoids. Braz. J. Med. Biol. Res. 2003, 36, 1613-1620.
82. Halliwell, B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch. Biochem. Biophys. 2008, 476, 107-112.
83. Nijveldt, R.J.; van Nood, E.; van Hoorn, D.E.; Boelens, P.G.; van Norren, K.; van Leeuwen, P.A. Flavonoids: A review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74, 418-425.
84. Simonyi, A.; Wang, Q.; Miller, R.L.; Yusof, M.; Shelat, P.B.; Sun, A.Y.; Sun, G.Y. Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol. Neurobiol. 2005, 31, 135-147.
85. Inanami, O.; Watanabe, Y.; Syuto, B.; Nakano, M.; Tsuji, M.; Kuwabara, M. Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radic. Res. 1998, 29, 359-365.
86. Lee, S.; Suh, S.; Kim, S. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci. Lett. 2000, 287, 191-194.
87. Sutherland, B.A; Rahman, R.M; Appleton, I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J. Nutr. Biochem. 2006, 17, 291-306.
88. Lee, H.; Bae, J.H.; Lee, S.R. Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils. J. Neurosci. Res. 2004, 77, 892-900.
89. Hong, J.T.; Ryu, S.R.; Kim, H.J.; Lee, J.K.; Lee, S.H.; Yun, Y.P.; Lee, B.M.; Kim, P.Y. Protective effect of green tea extract on ischemia/reperfusion-induced brain injury in Mongolian gerbils. Brain Res. 2001, 888, 11-18.
90. Sinha, K.; Chaudhary, G.; Gupta, Y.K. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002, 71, 655-665.
91. Wang, Q.; Xu, J.; Rottinghaus, G.E.; Simonyi, A.; Lubahn, D.; Sun, G.Y.; Sun, A.Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002, 958, 439-447.
92. Das, S.; Mandal, A.K.; Ghosh, A.; Panda, S.; Das, N.; Sarkar, S. Nanoparticulated quercetin in combating age related cerebral oxidative injury. Curr. Aging Sci. 2008, 1, 169-174.
93. Shukla, P.K.; Khanna, V.K.; Ali, M.M.; Khan, M.Y.; Srimal, R.C. Anti-ischemic effect of curcumin in rat brain. Neurochem. Res. 2008, 33, 1036-1043.
94. Levites, Y.; Weinreb, O.; Maor, G.; Youdim, M.B.; Mandel, S. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 2001, 78, 1073-1082.
95. Andres-Lacueva, C.; Shukitt-Hale, B.; Galli, R.L.; Jauregui, O.; Lamuela-Raventos, R.M.; Joseph, J.A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 2005, 2, 111-120.
96. Balu, M.; Sangeetha, P.; Haripriya, D.; Panneerselvam, C. Rejuvenation of antioxidant system in central nervous system of aged rats by grape seed extract. Neurosci. Lett. 2005, 383, 295-300.
97. Rajeswari, A. Curcumin protects mouse brain from oxidative stress caused by 1-methyl-4-henyl-1,2,3,6-tetrahydropyridine. Eur. Rev. Med. Pharmacol. Sci. 2006, 10, 157-161.
98. Dani, C.; Pasquali, M.A.; Oliveira, M.R.; Umezu, F.M.; Salvador, M.; Henriques, J.A.; Moreira, J.C. Protective effects of purple grape juice on carbon tetrachloride-induced oxidative stress in brains of adult Wistar rats. J. Med. Food 2008, 11, 55-61.
99. Karuppagounder, S.S.; Pinto, J.T.; Xu, H.; Chen, H.L.; Beal, M.F.; Gibson, G.E. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease. Neurochem. Int. 2009, 54, 111-118.
100. Ritz, M.F.; Ratajczak, P.; Curin, Y.; Cam, E.; Mendelowitsch, A.; Pinet, F.; Andriantsitohaina, R. Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J. Nutr. 2008, 138, 519-525.
101. Simão, F.; Matté, A.; Matté, C.; Soares, F.M.; Wyse, A.T.; Netto, C.A.; Salbego, C.G. Resveratrol prevents oxidative stress and inhibition of Na(+)K(+)-ATPase activity induced by transient global cerebral ischemia in rats. J. Nutr. Biochem. 2011, 22, 921-928.
102. Wang, T.; Gu, J.; Wu, P.F.; Wang, F.; Xiong, Z.; Yang, Y.J.; Wu, W.N.; Dong, L.D.; Chen J.G. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radic. Biol Med. 2009, 47, 229-240.
103. West, T.; Atzeva, M.; Holtzman, D.M. Pomegranate polyphenols and resveratrol protect the neonatal brain against hypoxic-ischemic injury. Dev. Neurosci. 2007, 29, 363-372.
104. Shin, D.H.; Bae, Y.C.; Kim-Han, J.S.; Lee, J.H.; Choi, I.Y.; Son, K.H.; Kang, S.S.; Kim, W.K.; Han, B.H. Polyphenol amentoflavone affords neuroprotection against neonatal hypoxic-ischemic brain damage via multiple mechanisms. J. Neurochem. 2006, 96, 561-572.
105. Loren, D.J.; Seeram, N.P.; Schulman, R.N.; Holtzman, D.M. Maternal dietary supplementation with pomegranate juice is neuroprotective in an animal model of neonatal hypoxic-ischemic brain injury. Pediatr. Res. 2005, 57, 858-864.
106. Gottlieb, M.; Leal-Campanario, R.; Campos-Esparza, M.R.; Sánchez-Gómez, M.V.; Alberdi, E.; Arranz, A.; Delgado-García, J.M.; Gruart, A.; Matute, C. Neuroprotection by two polyphenols following excitotoxicity and experimental ischemia. Neurobiol. Dis. 2006, 23, 374-386.
107. Campos-Esparza, M.R.; Sánchez-Gómez, M.V.; Matute, C. Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium 2009, 45, 358-368.
108. Park, J.W.; Hong, J.S.; Lee, K.S.; Kim, H.Y.; Lee, J.J.; Lee, S.R. Green tea polyphenol (-)- epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia. J. Nutr. Biochem. 2010, 21, 1038-1044.
109. Cheng, G.; Zhang, X.; Gao, D.; Jiang, X.; Dong, W. Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Neurosci. Lett. 2009, 451, 105-108.
110. ArunaDevi, R.; Lata, S.; Bhadoria, B.K.; Ramteke, V.D.; Kumar, S.; Sankar, P.; Kumar, D.; Tandan, S.K. Neuroprotective effect of 5,7,3',4',5'-pentahydroxy dihydroflavanol-3-O-(2"-Ogalloyl)-beta-D-glucopyranoside, a polyphenolic compound in focal cerebral ischemia in rat. Eur. J. Pharmacol. 2010, 626, 205-212.
111. Wang, Q.; Sun, A.Y.; Simonyi, A.; Jensen, M.D.; Shelat, P.B.; Rottinghaus, G.E.; MacDonald, R.S.; Miller, D.K.; Lubahn, D.E.; Weisman, G.A., et al. Neuroprotective mechanisms of curcumin against cerebral ischemia-induced neuronal apoptosis and behavioral deficits. J. Neurosci. Res. 2005, 82, 138-148.
112. Panickar, K.S.; Polansky, M.M.; Anderson, R.A. Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures. Nutr. Neurosci. 2009, 12, 105-113.
113. Panickar, K.S.; Polansky, M.M.; Anderson, R.A. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Exp. Neurol. 2009, 216, 420-427.
114. Della-Morte, D.; Dave, K.R.; DeFazio, R.A.; Bao, Y.C.; Raval, A.P.; Perez-Pinzon, M.A. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009, 159, 993-1002.
115. Klatzo, I. Presidental address. Neuropathological aspects of brain edema. J. Neuropathol. Exp. Neurol. 1967, 26, 1-14.
116. Katzman, R.; Clasen, R.; Klatzo, I.; Meyer, J.S.; Pappius, H.M.; Waltz, A.G. Report of Joint Committee for Stroke Resources. IV. Brain edema in stroke. Stroke 1977, 8, 512-540.
117. Kimelberg, H.K. Current concepts of brain edema. Review of laboratory investigations. J. Neurosurg. 1995, 83, 1051-1059.
118. Ito, U.; Go, K.G.; Walker, J.T., Jr.; Spatz, M.; Klatzo, I. Experimental cerebral ischemia in Mongolian gerbils III. Behaviour of the blood-brain barrier. Acta Neuropathol. 1976, 34, 1-6.
119. Klatzo, I. Pathophysiological aspects of brain edema. Acta Neuropathol. 1987, 72, 236-239.
120. Kuroiwa, T.; Ueki, M.; Chen, Q.; Suemasu, H.; Taniguchi, I.; Okeda, R. Biomechanical characteristics of brain edema: the difference between vasogenic-type and cytotoxic-type edema. Acta Neurochir. Suppl. (Wien). 1994, 60, 158-161.
121. Tan, W.K.; Williams, C.E.; During, M.J.; Mallard, C.E.; Gunning, M.I.; Gunn, A.J.; Gluckman, P.D. Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr. Res. 1996, 39, 791-797.
122. Albers, G.W. Diffusion-weighted MRI for evaluation of acute stroke. Neurology 1998, 51, S47-S49.
123. Siesjö, B.K. Cerebral circulation and metabolism. J. Neurosurg. 1984, 60, 883-908.
124. Vexler, Z.S.; Roberts, T.P.; Bollen, A.W.; Derugin, N.; Arieff, A.I. Transient cerebral ischemia. Association of apoptosis induction with hypoperfusion. J. Clin. Invest. 1997, 99, 1453-1459.
125. Mellergård, P.; Bengtsson, F.; Smith, M.L.; Riesenfeld, V.; Siesjö, B.K. Time course of early brain edema following reversible forebrain ischemia in rats. Stroke 1989, 20, 1565-1570.
126. Ito, U.; Ohno, K.; Nakamura, R.; Suganuma, F.; Inaba, Y. Brain edema during ischemia and after restoration of blood flow. Measurement of water, sodium, potassium content and plasma protein permeability. Stroke 1979, 10, 542-547.
127. DeLaPaz, R.L.; Shibata, D.; Steinberg, G.K.; Zarnegar, R.; George, C. Acute cerebral ischemia in rabbits: Correlation between MR and histopathology. AJNR Am. J. Neuroradiol. 1991, 12, 89-95.
128. Dias, L.A.; Colli, B.O.; Coutinho Netto, J.; Lachat, J.J. Focal cerebral ischaemia induced by middle cerebral artery occlusion and the neuroprotective effect of ketoprofen in rats. Arq. Neuropsiquiatr. 2000, 58, 1047-1054.
129. Melgar, M.A.; Rafols, J.; Gloss, D.; Diaz, F.G. Postischemic reperfusion: ultrastructural blood brain barrier and hemodynamic correlative changes in an awake model of transient forebrain ischemia. Neurosurgery 2005, 56, 571-581.
130. Garcia, J.H.; Liu, K.F.; Ho, K.L. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke 1995, 26, 636-642.
131. Zhang, K.; Lindsberg, P.J.; Tatlisumak, T.; Kaste, M.; Olsen, H.S.; Andersson, L.C. Stanniocalcin: A molecular guard of neurons during cerebral ischemia. Proc. Natl. Acad. Sci. USA 2000, 97, 3637-3642.
132. Dewar, D.; Underhill, S.M.; Goldberg, M.P. Oligodendrocytes and ischemic brain injury. J. Cereb. Blood Flow Metab. 2003, 23, 263-274.
133. Kuroiwa, T.; Shibutani, M.; Okeda, R. Nonhyperemic blood flow restoration and brain edema in experimental focal cerebral ischemia. J. Neurosurg. 1989, 70, 73-80.
134. Nakagawa, Y.; Fujimoto, N.; Matsumoto, K.; Cervós-Navarro, J. Morphological changes in acute cerebral ischemia after occlusion and reperfusion in the rat. Adv. Neurol. 1990, 52, 21-27.
135. del Zoppo, G.J. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience 2009, 158, 972-982.
136. Ayata, C.; Ropper, A.H. Ischaemic brain oedema. J. Clin. Neurosci. 2002, 9, 113-124.
137. Liang, D.; Bhatta, S.; Gerzanich, V.; Simard, J.M. Cytotoxic edema: Mechanisms of pathological cell swelling. Neurosurg. Focus. 2007, 22, E2.
138. Panickar, K.S.; Anderson, R.A. Role of dietary polyphenols in attenuating brain edema and cell swelling in cerebral ischemia. Recent Pat. CNS Drug Discov. 2010, 5, 99-108.
139. Kahle, K.T.; Simard, J.M.; Staley, K.J.; Nahed, B.V.; Jones, P.S.; Sun, D. Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport. Physiology (Bethesda) 2009, 24, 257-265.
140. 2+. Glia 1990, 3, 405-412.
141. Rutledge, E.M.; Kimelberg, H.K. Release of [3H]-D-aspartate from primary astrocyte cultures in response to raised external potassium. J. Neurosci. 1996, 16, 7803-7811.
142. Kimelberg, H.K. Astrocytic swelling in cerebral ischemia as a possible cause of injury and target for therapy. Glia 2005, 50, 389-397.
143. MacGregor, D.G.; Avshalumov, M.V.; Rice, M.E. Brain edema induced by in vitro ischemia: causal factors and neuroprotection. J. Neurochem. 2003, 85, 1402-1411.
144. Rama Rao, K.V.; Chen, M.; Simard, J.M.; Norenberg, M.D. Suppression of ammonia-induced astrocyte swelling by cyclosporin A. J. Neurosci. Res. 2003, 74, 891-897.
145. Panickar, K.S.; Jayakumar, A.R.; Norenberg, M.D. The mitochondrial permeability transition and MAP kinase phosphorylation in the mechanism of astrocyte swelling following in vitro trauma. Soc. Neurosci Abstr. 2006, Abstr #180:14.
146. Jayakumar, A.R.; Rao, K.V.; Panickar, K.S.; Moriyama, M.; Reddy, P.V.; Norenberg, M.D. Trauma-induced cell swelling in cultured astrocytes. J. Neuropathol. Exp. Neurol. 2008, 67, 417-427.
147. Zoratti, M.; Szabò, I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1995, 1241, 139-176.
148. Bernardi, P.; Krauskopf, A.; Basso, E.; Petronilli, V.; Blachly-Dyson, E.; di Lisa, F.; Forte, M.A. The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 2006, 273, 2077-2099.
149. Gunter, T.E.; Pfeiffer, D.R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 1990, 258, C755-C786.
150. Zamzami, N.; Hirsch, T.; Dallaporta, B.; Petit, P.X.; Kroemer, G. Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 1997, 29, 185-193.
151. Schweizer, M.; Schlegel, J.; Baumgartner, D.; Richter, C. Sensitivity of mitochondrial peptidylprolyl cis-trans isomerase, pyridine nucleotide hydrolysis and Ca2+ release to cyclosporine A and related compounds. Biochem. Pharmacol. 1993, 45, 641-646.
152. Connern, C.P.; Halestrap, A.P. Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calciumsensitive non-specific channel. Biochem. J. 1994, 302, 321-324.
153. Yan, Y.; Dempsey, R.J.; Flemmer, A.; Forbush, B.; Sun, D. Inhibition of Na(+)-K(+)-Cl(-) cotransporter during focal cerebral ischemia decreases edema and neuronal damage. Brain Res. 2003, 961, 22-31.
154. Chen, H.; Sun, D. The role of Na-K-Cl co-transporter in cerebral ischemia. Neurol. Res. 2005, 27, 280-286.
155. Chen, M.; Dong, Y.; Simard, J.M. Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain. J. Neurosci. 2003, 23, 8568-8577.
156. Simard, J.M.; Chen, M.; Tarasov, K.V.; Bhatta, S.; Ivanova, S.; Melnitchenko, L.; Tsymbalyuk, N.; West, G.A.; Gerzanich, V. Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med. 2006, 12, 433-440.
157. Manley, G.T.; Fujimura, M.; Ma, T.; Noshita, N.; Filiz, F.; Bollen, A.W.; Chan, P.; Verkman, A.S. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat. Med. 2000, 6, 159-163.
158. Kim, J.H.; Lee, Y.W.; Park, K.A.; Lee, W.T.; Lee, J.E. Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia. J. Cereb. Blood Flow Metab. 2010, 30, 943-949.
159. Agre, P. The aquaporin water channels. Proc. Am. Thorac. Soc. 2006, 3, 5-13.
160. Amiry-Moghaddam, M.; Ottersen, O.P. The molecular basis of water transport in the brain. Nat. Rev. Neurosci. 2003, 4, 991-1001.
161. Nagelhus, E.A.; Horio, Y.; Inanobe, A.; Fujita, A.; Haug, F.M.; Nielsen, S.; Kurachi, Y.; Ottersen, O.P. Immunogold evidence suggests that coupling of K+ siphoning and water transport in rat retinal Müller cells is mediated by a coenrichment of Kir4.1 and AQP4 in specific membrane domains. Glia 1999, 26, 47-54.
162. Saadoun, S.; Papadopoulos, M.C.; Krishna, S. Water transport becomes uncoupled from K+ siphoning in brain contusion, bacterial meningitis, and brain tumours: immunohistochemical case review. J. Clin. Pathol. 2003, 56, 972-975.
163. Heo, J.H.; Lucero, J.; Abumiya, T.; Koziol, J.A.; Copeland, B.R.; del Zoppo, G.J. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 1999, 19, 624-633.
164. del Zoppo, G.J.; Schmid-Schönbein, G.W.; Mori, E.; Copeland, B.R.; Chang, C.M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991, 22, 1276-1283.
165. Wang Y.J.; He, F.; Li X.L. The neuroprotection of resveratrol in the experimental cerebral ischemia. Zhonghua Yi Xue Za Zhi 2003, 83, 534-536 (in chinese).
166. Panickar, K.S.; Polansky, M.M.; Anderson, R.A. Myricetin and quercetin attenuate ischemic injury in glial cultures by different mechanisms. Available online: http://ppmq.ars.usda.gov/research/publications/publications.htm?SEQ_NO_115=240566 (access on 16 November 2011).
167. Panickar, K.S.; Anderson, R.A. Mechanisms underlying the protective effects of myricetin and quercetin following oxygen-glucose deprivation-induced cell swelling and the reduction in glutamate uptake in glial cells. Neuroscience 2011, 183, 1-14.
168. Jayakumar, A.R.; Panickar, K.S.; Murthy, Ch.R.K.; Norenberg, M.D. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J. Neurosci. 2006, 26, 4774-4784.
169. Unterberg, A.W.; Stover, J.; Kress, B.; Kiening, K.L. Edema and brain trauma. Neuroscience 2004, 129, 1021-1029.
170. Marmarou, A. Pathophysiology of traumatic brain edema: Current concepts. Acta Neurochir. Suppl. 2003, 86, 7-10.
171. Xue, D.; Slivka, A.; Buchan, A.M. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats. Stroke 1992, 23, 894-899.
172. Cherubini, A.; Ruggiero, C.; Morand, C.; Lattanzio, F.; Dell'aquila, G.; Zuliani, G.; Di Iorio, A.; Andres-Lacueva, C. Dietary antioxidants as potential pharmacological agents for ischemic stroke. Curr. Med. Chem. 2008, 15, 1236-1248.
173. Remacle, J.; Raes, M.; Toussaint, O.; Renard, P.; Rao, G. Low levels of reactive oxygen species as modulators of cell function. Mutat. Res. 1995, 316, 103-122.
174. Sen, C.K.; Packer, L. Antioxidant and redox regulation of gene transcription. FASEB J. 1996, 10, 709-720.
175. Liu, J.R.; Zhao, Y.; Patzer, A.; Staak, N.; Boehm, R.; Deuschl, G.; Culman, J.; Bonny, C.; Herdegen, T.; Eschenfelder, C. The JNK-inhibitor XG-102 enhances the neuroprotection of hyperbaric oxygen after cerebral ischaemia in adult rats. Neuropathol. Appl. Neurobiol. 2010, 36, 211-224.
176. Yatsushige, H.; Ostrowski, R.P.; Tsubokawa, T.; Colohan, A.; Zhang, J.H. Role of c-Jun N-terminal kinase in early brain injury after subarachnoid hemorrhage. J. Neurosci. Res. 2007, 85, 1436-1448.
177. Wacker, B.K.; Park, T.S.; Gidday, J.M. Hypoxic preconditioning-induced cerebral ischemic tolerance: role of microvascular sphingosine kinase2. Stroke 2009, 40, 3342-3348.
178. Foster, K.A.; Regan, H.K.; Danziger, A.P.; Detwiler, T.; Kwon, N.; Rickert, K.; Lynch, J.J.; Regan, C.P. Attenuation of edema and infarct volume following focal cerebral ischemia by early but not delayed administration of a novel small molecule KDR kinase inhibitor. Neurosci. Res. 2009, 63, 10-16.
179. Nito, C.; Kamada, H.; Endo, H.; Niizuma, K.; Myer, D.J.; Chan, P.H. Role of the p38 mitogenactivated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J. Cereb. Blood Flow Metab. 2008, 28, 1686-1696.
180. de La Paz, L.D.; Lezama, R.; Torres-Marquez, M.E.; Pasantes-Morales, H. Tyrosine kinases and amino acid efflux under hyposmotic and ischaemic conditions in the chicken retina. Pflugers Arch. 2002, 445, 87-96.
181. Doukas, J.; Mahesh, S.; Umeda, N.; Kachi, S.; Akiyama, H.; Yokoi, K.; Cao, J.; Chen, Z.; Dellamary, L.; Tam, B., et al. Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema. J. Cell. Physiol. 2008, 216, 29-37.
182. Boron, W.F.; Hogan, E.; Russell, J.M. PH-sensitive activation of the intracellular-pH regulation system in squid axons by ATP-gamma-S. Nature 1988, 332, 262-365.
183. Bae, H.R.; Verkman, A.S. Protein kinase A regulates chloride conductance in endocytic vesicles from proximal tubule. Nature 1990, 348, 637-639.
184. Gutierrez-Diaz, J.A., Cuevas, P.; Reimers, D.; Dujovny, M.; Diaz, F.G.; Ausman, J.I. Quantitative electron microscopic study of calcium accumulation in cerebral ischemia mitochondria. Surg. Neurol. 1985, 24, 67-72.
185. Siesjö, B.K. Historical overview. Calcium, ischemia, and death of brain cells. Ann. NY Acad. Sci. 1988, 522, 638-661.
186. Plesnila, N.; Ringel, F.; Chang, R.C.; Staub, F.; Baethmann, A. Relevance of calcium homeostasis in glial cell swelling from acidosis. Acta Neurochir. Suppl. 1998, 71, 203-205.
187. 2+. Neurosci. Lett. 2006, 398, 306-309.
188. Fischer, R.; Schliess, F.; Häussinger, D. Characterization of the hypo-osmolarity-induced Ca2+ response in cultured rat astrocytes. Glia 1997, 20, 51-58.
189. Wang, H.; Joseph, J.A. Structure-activity relationships of quercetin in antagonizing hydrogen peroxide-induced calcium dysregulation in PC12 cells. Free Radic. Biol Med. 1999, 27, 683-694.
190. Wallace, CH.; Baczkó, I.; Jones, L.; Fercho, M.; Light, P.E. Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. Br. J. Pharmacol. 2006, 149, 657-665.
191. Kanda, T.; Akiyama, H.; Yanagida, A.; Tanabe, M.; Goda, Y.; Toyoda, M.; Teshima, R.; Saito, Y. Inhibitory effects of apple polyphenol on induced histamine release from RBL-2H3 cells and rat mast cells. Biosci. Biotechnol. Biochem. 1998, 62, 1284-1289.
192. Lee, J.H.; Song, D.K.; Jung, C.H.; Shin, D.H.; Park, J.; Kwon, T.K.; Jang, B.C.; Mun, K.C.; Kim, S.P.; Suh, S.I., et al. (-)-Epigallocatechin gallate attenuates glutamate-induced cytotoxicity via intracellular Ca modulation in PC12 cells. Clin. Exp. Pharmacol. Physiol. 2004, 31, 530-536.
193. Sakagami, H.; Kuribayashi, N.; Iida, M.; Sakagami, T.; Takeda, M.; Fukuchi, K.; Gomi, K.; Ohata, H.; Momose, K.; Kawazoe, Y., et al. Induction of DNA fragmentation by tannin- and lignin-related substances. Anticancer Res. 1995, 15, 2121-2128.
194. Martin, S.; Andriambeloson, E.; Takeda, K.; Andriantsitohaina, R. Red wine polyphenols increase calcium in bovine aortic endothelial cells: A basis to elucidate signalling pathways leading to nitric oxide production. Br. J. Pharmacol. 2002, 135, 1579-1587.
195. Sims, N.R.; Finegan, J.M.; Blass, J.P. Effects of postdecapitative ischemia on mitochondrial respiration in brain tissue homogenates. J. Neurochem. 1986, 47, 506-511.
196. Stanimirovic, D.; Satoh, K. Inflammatory mediators of cerebral endothelium: A role in ischemic brain inflammation. Brain Pathol. 2000, 10, 113-126.
197. Pardridge, W.M.; Connor, J.D.; Crawford, I.L. Permeability changes in the blood-brain barrier: causes and consequences. CRC Crit. Rev. Toxicol. 1975, 3, 159-199.
198. Cipolla, M.J.; Crete, R.; Vitullo, L.; Rix, R.D. Transcellular transport as a mechanism of bloodbrain barrier disruption during stroke. Front. Biosci. 2004, 9, 777-785.
199. Musim, M.N.; Khadzhaǐ, IaI.; Litvinenko, V.I.; Ammosov, A.S. Anti-inflammatory activity of a polyphenolic preparation obtained from peppermint. Farm. Zh. 1976, 2, 76-79.
200. Agarwal, R.; Katiyar, S.K.; Khan, S.G.; Mukhtar, H. Protection against ultraviolet B radiation induced effects in the skin of SKH-1 hairless mice by a polyphenolic fraction isolated from green tea. Photochem. Photobiol. 1993, 58, 695-700.
201. Gao, D.; Zhang, X.; Jiang, X.; Peng, Y.; Huang, W.; Cheng, G.; Song, L. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci. 2006, 78, 2564-2570.
202. Bolaños, J.P.; Peuchen, S.; Heales, S.J.; Land, J.M.; Clark, J.B. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J. Neurochem. 1994, 63, 910-916.
203. Zhang, S.; Liu, Y.; Zhao, Z.; Xue, Y. Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia. Neurol. Res. 2010, 32, 963-970.
204. Jiang, J.; Wang, W.; Sun, Y.J.; Hu, M.; Li, F.; Zhu, D.Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur. J. Pharmacol. 2007, 561, 54-62.
205. Thiyagarajan, M.; Sharma, S.S. Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Life Sci. 2004, 74, 969-985.
206. Dohare, P.; Garg, P.; Jain, V.; Nath, C.; Ray, M. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav. Brain Res. 2008, 193, 289-297.
207. Lim, G.P.; Chu, T.; Yang, F.; Beech, W.; Frautschy, S.A.; Cole, G.M. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 2001, 21, 8370-8377.
208. Lazovic, J.; Basu, A.; Lin, H.W.; Rothstein, R.P.; Krady, J.K.; Smith, M.B.; Levison, S.W. Neuroinflammation and both cytotoxic and vasogenic edema are reduced in interleukin-1 type 1 receptor-deficient mice conferring neuroprotection. Stroke 2005, 36, 2226-2231.
209. Cao, H.; Urban, J.F., Jr.; Anderson, R.A. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J. Nutr. 2008, 138, 833-840.
210. Panickar, K.S.; Cao, H.C.; Qin, B.; Anderson, R.A. Molecular Targets and Therapeutic Uses of Cinnamon. In Molecular Targets and Therapeutic Uses of Spices: Modern Uses for Ancient Medicine; Aggarwal, B.B., Kunnumakkara, A.B., Eds.; Monograph of Spices. World Scientific Publishing Co Inc.: Singapore, 2009; pp. 87-115.
211. Fujiki, H.; Suganuma, M.; Okabe, S.; Sueoka, E.; Suga, K.; Imai, K.; Nakachi, K.; Kimura, S. Mechanistic findings of green tea as cancer preventive for humans. Proc. Soc. Exp. Biol. Med. 1999, 220, 225-228.
212. Bu, S.Y.; Lerner, M.; Stoecker, B.J.; Boldrin, E.; Brackett, D.J.; Lucas, E.A.; Smith, B.J. Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators. Calcif. Tissue Int. 2008, 82, 475-488.
213. di Paola, R.; Mazzon, E.; Muià, C.; Genovese, T.; Menegazzi, M.; Zaffini, R.; Suzuki, H.; Cuzzocrea, S. Green tea polyphenol extract attenuates lung injury in experimental model of carrageenan-induced pleurisy in mice. Respir. Res. 2005, 6, doi:10.1186/1465-9921-6-66.
214. Subbaramaiah, K.; Chung, W.J.; Michaluart, P.; Telang, N.; Tanabe, T.; Inoue, H.; Jang, M.; Pezzuto, J.M.; Dannenberg, A.J. Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 1998, 273, 21875-21882.
215. Li, Y.T.; Shen, F.; Liu, B.H.; Cheng, G.F. Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells. Acta Pharmacol. Sin. 2003, 24, 1167-1171.